公开(公告)号：US20190183416A1

公开(公告)日：2019-06-20

申请号：US16327253

申请日：2017-08-17

申请人： GALDERMA RESEARCH AND DEVELOPMENT

发明人： Laurent PETIT ,  Laurent CHANTALAT

IPC分类号： A61B5/00

CPC分类号： A61B5/4833 ,  A61B5/004 ,  A61B5/0071 ,  A61B5/441 ,  A61B5/444 ,  A61B5/4842 ,  A61B5/6898

摘要： A method for evaluating skin conditions on a skin area of a user using an ultraviolet light device that can connect to a mobile device and a user input is disclosed. The method for evaluating skin conditions includes the steps of illuminating the skin area of the user with the ultraviolet light device operated by the mobile device, capturing an image of the illuminated skin area with an image capture device, processing the image with a processing program to determine the level of fluorescence on the skin area, and mapping progress of treatment of the skin condition based on the processed image compared to a control image.

公开(公告)号：US20220160708A1

公开(公告)日：2022-05-26

申请号：US17650270

申请日：2022-02-08

申请人： Galderma Research and Development

发明人： Mario LACOUTURE ,  Philippe ANDRES

IPC分类号： A61K31/498 ,  A61P17/00 ,  A61K31/137 ,  A61K31/4174 ,  A61K31/7048

摘要： The present invention relates to a method of preventing or reducing dermatological side effects of the therapeutic agents in a subject without substantial loss in efficacy, where the therapeutic agents would otherwise have significant effects. In particular, this beneficial effect is achieved by using an alpha-2 adrenergic agonist to isolate body areas from pharmacological effects of the therapeutic agents, such as a chemotherapeutic agent, and to prevent or reduce inflammatory processes.

公开(公告)号：US11278548B2

公开(公告)日：2022-03-22

申请号：US16630989

申请日：2018-07-13

申请人： Galderma Research and Development

发明人： Mario Lacouture ,  Philippe Andres

IPC分类号： A61K31/498 ,  A61P17/00 ,  A61K31/137 ,  A61K31/4174 ,  A61K31/7048 ,  A61K45/06

摘要： A method of preventing or reducing dermatological side effects of the therapeutic agents in a subject without substantial loss in efficacy, where the therapeutic agents would otherwise have significant effects, is described. In particular, the beneficial effects are achieved by using an alpha-2 adrenergic agonist to isolate body areas from pharmacological effects of the therapeutic agents, such as a chemotherapeutic agent, and to prevent or reduce inflammatory processes.

公开(公告)号：US20200222396A1

公开(公告)日：2020-07-16

申请号：US16630989

申请日：2018-07-13

申请人： Galderma Research and Development

发明人： Mario LACOUTURE ,  Philippe ANDRES

IPC分类号： A61K31/498 ,  A61K31/137 ,  A61K31/4174 ,  A61K31/7048 ,  A61P17/00

摘要： A method of preventing or reducing dermatological side effects of the therapeutic agents in a subject without substantial loss in efficacy, where the therapeutic agents would otherwise have significant effects, is described. In particular, the beneficial effects are achieved by using an alpha-2 adrenergic agonist to isolate body areas from pharmacological effects of the therapeutic agents, such as a chemotherapeutic agent, and to prevent or reduce inflammatory processes.

公开(公告)号：US11162831B2

公开(公告)日：2021-11-02

申请号：US16622973

申请日：2018-05-23

申请人： Galderma Research and Development

发明人： Jian Yan

IPC分类号： G01F11/00 ,  G01F11/02 ,  B65D83/00

摘要： The device for packaging and dispensing a product including a storage container (12) provided with at least one variable-volume compartment (22) containing the product, a pressurizing means (30) able to permanently pressurize the product contained in the compartment, and a dispensing head (14) having a mounting base (32) attached to the container. The dispensing head further includes a dispensing member (34) mounted inside the mounting base (32) with the ability to move in rotation, a piston (36) with the ability to move in translation inside the dispensing member (34) and able to delimit, inside the said member, opposing first and second metering chambers (60, 62), and at least first and second orifices (56, 58) formed on the dispensing member (34) and respectively able to be in direct fluidic communication with the first and second metering chambers (60, 62).

公开(公告)号：US11375946B2

公开(公告)日：2022-07-05

申请号：US16327253

申请日：2017-08-17

申请人： GALDERMA RESEARCH AND DEVELOPMENT ,  Laurent Petit ,  Laurent Chantalat

发明人： Laurent Petit ,  Laurent Chantalat

IPC分类号： A61B5/00

摘要： A method for evaluating skin conditions on a skin area of a user using an ultraviolet light device that can connect to a mobile device and a user input is disclosed. The method for evaluating skin conditions includes the steps of illuminating the skin area of the user with the ultraviolet light device operated by the mobile device, capturing an image of the illuminated skin area with an image capture device, processing the image with a processing program to determine the level of fluorescence on the skin area, and mapping progress of treatment of the skin condition based on the processed image compared to a control image.